|
Volumn 28, Issue 6, 2005, Pages 552-553
|
Biosimilars: How similar are they?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOSIMILAR;
BIOLOGICAL PRODUCT;
BIOSIMILAR DRUG;
ERYTHROPOIETIN;
GENERIC DRUG;
HUMAN GROWTH HORMONE;
INTERFERON;
NEW DRUG;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT HUMAN INSULIN;
RECOMBINANT PROTEIN;
UNCLASSIFIED DRUG;
BIOMEDICINE;
BIOTECHNOLOGY;
DNA MODIFICATION;
DRUG CONFORMATION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG LABELING;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG POTENCY;
DRUG QUALITY;
DRUG SAFETY;
DRUG STABILITY;
DRUG SURVEILLANCE PROGRAM;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
IMMUNITY;
MOLECULAR WEIGHT;
PATENT;
PRESCRIPTION;
PURE RED CELL ANEMIA;
|
EID: 23144452293
PISSN: 03913988
EISSN: None
Source Type: Journal
DOI: 10.1177/039139880502800602 Document Type: Editorial |
Times cited : (5)
|
References (0)
|